BIOMAT Database Logo BIOMAT Database Logo

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy. 2016

Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
University of Pittsburgh, Pennsylvania.

We measured plasma human immunodeficiency virus type 1 (HIV-1) RNA levels by means of single-copy assay in 334 participants receiving virologically suppressive antiretroviral therapy (ART). A residual viremia load of ≥1 copy/mL after 4 years of ART was predicted by a higher pre-ART HIV-1 RNA level, higher CD8(+) T-cell count during treatment, and a lower ratio of CD4+ T cells to CD8+ T cells during treatment but not by initial ART regimen. In a longitudinal subset of 64 individuals, continued decay of the plasma HIV-1 RNA level was observed, with an average annual decrease of 6% and an estimated half-life of 11.5 years. In contrast to prior reports, the persistent viremia level continues to slowly decline during years 4-12 of suppressive ART. BACKGROUND NCT00001137.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016516 CD4-CD8 Ratio Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS. T4-T8 Ratio,CD4 CD8 Ratio,CD4-CD8 Ratios,T4 T8 Ratio,T4-T8 Ratios

Related Publications

Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
January 2020, Journal of the International Association of Providers of AIDS Care,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.
July 2011, The Journal of infectious diseases,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.
January 2004, Mathematical biosciences,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
May 2000, AIDS (London, England),
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Advances in detection and monitoring of plasma viremia in HIV-infected individuals receiving antiretroviral therapy.
March 2013, Current opinion in HIV and AIDS,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya.
September 2023, EClinicalMedicine,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
June 2006, The Journal of infectious diseases,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.
October 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
February 2005, The Journal of infectious diseases,
Sharon A Riddler, and Evgenia Aga, and Ronald J Bosch, and Barbara Bastow, and Margaret Bedison, and David Vagratian, and Florin Vaida, and Joseph J Eron, and Rajesh T Gandhi, and John W Mellors, and
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
January 2021, Frontiers in immunology,
Copied contents to your clipboard!